For the twelve months ended Aug 31, 2026, Saratoga Investment Corp New reported $109.43M of revenue and -$4.18M of net income.
SAR revenue was $28.80M in fiscal Q2 2027 (ended Aug 31, 2026), up 9.2% from a year earlier and up 2.4% from the prior quarter. For the full fiscal 2026 it was $106.90M, down 18.4% from fiscal 2025. It rose in 2 of the last 3 fiscal years.
SAR net income was -$6.66M in fiscal Q2 2027 (ended Aug 31, 2026), compared with $13.29M a year earlier. For the full fiscal 2026 it was $36.60M, up 30.3% from fiscal 2025. Compound annual growth was +19.9% over 5 years. It rose in 3 of the last 5 fiscal years.
SAR diluted EPS was -$0.41 in fiscal Q2 2027 (ended Aug 31, 2026), compared with $0.84 a year earlier. For the full fiscal 2026 it was $2.31, up 14.4% from fiscal 2025. Compound annual growth was +11.8% over 5 years.
| Line item | Feb 28, 2026 | Feb 28, 2025 | Feb 29, 2024 | Feb 28, 2023 | Feb 28, 2022 | Feb 28, 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106.90M | $131.02M | $127.79M | $85.22M | - | - |
| Selling, general and admin | $2.23M | $1.90M | $2.24M | $2.33M | $1.66M | $1.43M |
| Income tax | -$138.2K | $412.0K | $42.9K | -$153.0K | -$39.6K | $667 |
| Net income | $36.60M | $28.09M | $8.93M | $24.68M | $45.74M | $14.78M |
| EPS, basic | $2.31 | $2.02 | $0.71 | $2.06 | $3.99 | $1.32 |
| EPS, diluted | $2.31 | $2.02 | $0.71 | $2.06 | $3.99 | $1.32 |
| Diluted shares | 15.9M | 13.9M | 12.7M | 12.0M | - | - |
| Line item | Feb 28, 2026 | Feb 28, 2025 | Feb 29, 2024 | Feb 28, 2023 | Feb 28, 2022 | Feb 28, 2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $1.68M | $204.72M | $8.69M | $96.08M | $52.87M | $29.92M |
| Total assets | $1.14B | $1.19B | $1.19B | $1.08B | $876.24M | - |
| Current liabilities | - | $798.88M | - | - | - | - |
| Long-term debt | - | - | $820.4K | - | - | - |
| Total debt | $739.38M | $793.88M | $820.4K | $728.38M | - | - |
| Total liabilities | $743.11M | $798.88M | $820.98M | $731.20M | $520.46M | - |
| Shareholders' equity | $396.16M | $392.67M | $370.22M | $346.96M | $355.78M | $304.19M |
| Line item | Feb 28, 2026 | Feb 28, 2025 | Feb 29, 2024 | Feb 28, 2023 | Feb 28, 2022 | Feb 28, 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$88.03M | $197.54M | -$157.21M | -$130.37M | -$203.13M | -$62.35M |
| Financing cash flow | -$94.91M | -$33.32M | $101.64M | $173.58M | $226.09M | $52.81M |
| Dividends paid | $52.36M | $40.75M | $32.05M | $22.67M | $18.16M | $11.27M |
| Share repurchases | $54.3K | - | $2.16M | $10.82M | - | - |
| Line item | Feb 28, 2026 | Feb 28, 2025 | Feb 29, 2024 | Feb 28, 2023 | Feb 28, 2022 | Feb 28, 2021 |
|---|---|---|---|---|---|---|
| Revenue growth, YoY | -18.4% | 2.5% | 50.0% | - | - | - |
| Net income growth, YoY | 30.3% | 214.4% | -63.8% | -46.0% | 209.5% | - |
| EPS growth, YoY | 14.4% | 184.5% | -65.5% | -48.4% | 202.3% | - |
| Net margin | 34.2% | 21.4% | 7.0% | 29.0% | - | - |
| Return on equity | 9.2% | 7.2% | 2.4% | 7.1% | 12.9% | 4.9% |
| Return on assets | 3.2% | 2.4% | 0.7% | 2.3% | 5.2% | - |
| Debt to equity | 1.87 | 2.02 | 0.00 | 2.10 | - | - |
| Line item | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.80M | $28.12M | $25.79M | $26.72M | $26.38M | $28.00M | $26.59M | $30.76M | $39.37M | $34.31M | $33.24M | $32.66M |
| Selling, general and admin | $681.0K | $600.3K | $279.3K | $888.8K | $412.8K | $645.4K | -$289.0K | $759.9K | $821.6K | $609.1K | $283.7K | $660.1K |
| Interest expense | - | - | - | - | $900.0K | $800.0K | - | - | $500.0K | $300.0K | - | $900.0K |
| Income tax | $46.1K | -$16.6K | $23.4K | -$204.7K | -$11.3K | $54.5K | $313.8K | $36.6K | $121.9K | -$60.3K | $54.1K | $219.9K |
| Net income | -$6.66M | -$6.90M | -$2.61M | $12.00M | $13.29M | $13.93M | -$676.8K | $8.83M | $13.32M | $6.61M | $5.31M | -$4.06M |
| EPS, basic | -$0.41 | -$0.42 | -$0.18 | $0.74 | $0.84 | $0.91 | -$0.07 | $0.64 | $0.97 | $0.48 | - | -$0.31 |
| EPS, diluted | -$0.41 | -$0.42 | -$0.18 | $0.74 | $0.84 | $0.91 | -$0.07 | $0.64 | $0.97 | $0.48 | - | -$0.31 |
| Diluted shares | 16.2M | 16.3M | - | 16.1M | 15.8M | 15.3M | - | 13.8M | 13.7M | 13.7M | - | 13.1M |
| Line item | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $80.09M | $46.14M | $1.68M | $52.30M | $200.80M | $224.29M | $204.72M | $250.16M | $162.00M | $93.30M | $8.69M | $47.03M |
| Total assets | $1.26B | $1.20B | $1.14B | $1.20B | $1.21B | $1.20B | $1.19B | $1.22B | $1.21B | $1.20B | $1.19B | $1.17B |
| Current liabilities | - | - | - | - | - | $805.90M | $798.88M | - | - | - | - | - |
| Long-term debt | - | - | - | - | - | - | - | - | $837.9K | $830.9K | $820.4K | - |
| Total debt | $902.38M | $817.38M | $739.38M | $774.38M | $786.38M | $791.38M | $793.88M | $837.88M | $837.9K | $830.9K | $820.4K | $811.4K |
| Total liabilities | $903.69M | $818.97M | $743.11M | $783.76M | $795.71M | - | $798.88M | $845.05M | - | $833.93M | $820.98M | - |
| Shareholders' equity | $352.58M | $378.45M | $396.16M | $413.21M | $410.50M | $396.37M | $392.67M | $374.87M | $372.05M | $367.86M | $370.22M | $359.56M |
| Line item | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$27.77M | -$25.97M | -$92.42M | -$8.60M | -$19.30M | $32.29M | -$19.92M | $94.16M | $71.15M | $52.15M | -$20.66M | -$18.55M |
| Financing cash flow | $62.83M | $64.99M | -$55.36M | -$22.64M | -$4.18M | -$12.73M | -$25.52M | -$6.00M | -$2.44M | $644.7K | $14.14M | $17.15M |
| Dividends paid | $10.81M | $10.80M | $14.38M | $10.80M | $10.51M | $16.67M | $13.69M | $8.96M | $9.12M | $8.98M | $8.89M | $8.43M |
| Share repurchases | - | - | - | - | - | - | - | - | - | - | $0 | $0 |
| Line item | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 9.2% | 0.4% | -3.0% | -13.1% | -33.0% | -18.4% | -20.0% | -5.8% | - | - | - | - |
| Net income growth, YoY | - | - | - | 35.8% | -0.2% | 110.8% | - | - | 68.7% | - | -72.4% | - |
| EPS growth, YoY | - | - | - | 15.6% | -13.4% | 89.6% | - | - | 49.2% | - | - | - |
| Net margin | -23.1% | -24.6% | -10.1% | 44.9% | 50.4% | 49.8% | -2.5% | 28.7% | 33.8% | 19.3% | 16.0% | -12.4% |
| Debt to equity | 2.56 | 2.16 | 1.87 | 1.87 | 1.92 | 2.00 | 2.02 | 2.24 | 0.00 | 0.00 | 0.00 | 0.00 |
Source: XBRL data Saratoga Investment Corp New files with the SEC, latest filing dated Oct 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| SAR | $109.43M | -2.1% | -$4.18M | -3.8% | $202.6M |
| BX | $16.08B | +22.1% | $3.56B | 22.1% | $93.11B |
| KKR | $20.35B | +19.8% | $3.41B | 16.8% | $88.05B |
| APO | $30.82B | +12.2% | -$918.00M | -3.0% | $72.15B |
| ARES | $5.76B | +7.6% | $432.80M | 7.5% | $46.10B |
| AMP | $20.14B | +8.8% | $4.16B | 20.7% | $44.99B |
| TROW | $7.70B | +6.9% | $2.19B | 28.4% | $23.64B |
| TPG | $5.17B | +21.6% | $268.72M | 5.2% | $18.89B |